UROPLASTY INC
DelistedCIK 890846fmd_087ET0E8476NYRKQZCVQ4R7NQFManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Apr 01, 2009 to Dec 31, 2014, 20 periods
Latest annual · FY2014
Millions- Total revenues
- 25
- Gross profit
- 22
- Operating income
- (5)
- Net income
- (5)
- Free cash flow
- (3)
Latest quarter · Q3 FY2015
Millions- Total revenues
- 7
- Gross profit
- 6
- Operating income
- (2)
- Net income
- (2)
- Free cash flow
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2011 to FY2014
- +21.3%
UROPLASTY INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2014 | FY2013 | Change | Source |
|---|---|---|---|---|
| Revenue | $24.6 million | $22.4 million | +9.6% | 10-K 2014-06-09 · proof |
| Gross profit | $21.5 million | $19.4 million | +10.9% | 10-K 2014-06-09 · proof |
| Operating income | -$5.3 million | -$3.3 million | 10-K 2014-06-09 · proof | |
| Net income | -$5.4 million | -$3.3 million | 10-K 2014-06-09 · proof | |
| Cash from operating activities | -$2.9 million | -$1.2 million | 10-K 2014-06-09 · proof | |
| Free cash flow | -$3.2 million | -$1.4 million | 10-K 2014-06-09 · proof | |
| Total assets | $17.3 million | $20 million | -13.7% | 10-K 2014-06-09 · proof |
| Total liabilities | $4.1 million | $3.4 million | +21.8% | 10-K 2014-06-09 · proof |
| Cash and cash equivalents | $8.7 million | $3.5 million | +145.7% | 10-K 2014-06-09 · proof |
- What was UROPLASTY INC's revenue in fiscal 2014?
- UROPLASTY INC reported revenue of $24.6 million for fiscal 2014 (the year ended Mar 31, 2014), against $22.4 million the year before (+9.6%). Source: the 10-K filed with the SEC on Jun 9, 2014. SEC
- What was UROPLASTY INC's gross profit in fiscal 2014?
- UROPLASTY INC reported gross profit of $21.5 million for fiscal 2014 (the year ended Mar 31, 2014), against $19.4 million the year before (+10.9%). Source: the 10-K filed with the SEC on Jun 9, 2014. SEC
- What was UROPLASTY INC's operating income in fiscal 2014?
- UROPLASTY INC reported operating income of -$5.3 million for fiscal 2014 (the year ended Mar 31, 2014), against -$3.3 million the year before. Source: the 10-K filed with the SEC on Jun 9, 2014. SEC
- What was UROPLASTY INC's net income in fiscal 2014?
- UROPLASTY INC reported net income of -$5.4 million for fiscal 2014 (the year ended Mar 31, 2014), against -$3.3 million the year before. Source: the 10-K filed with the SEC on Jun 9, 2014. SEC
- What was UROPLASTY INC's cash from operating activities in fiscal 2014?
- UROPLASTY INC reported cash from operating activities of -$2.9 million for fiscal 2014 (the year ended Mar 31, 2014), against -$1.2 million the year before. Source: the 10-K filed with the SEC on Jun 9, 2014. SEC
- What was UROPLASTY INC's free cash flow in fiscal 2014?
- UROPLASTY INC reported free cash flow of -$3.2 million for fiscal 2014 (the year ended Mar 31, 2014), against -$1.4 million the year before. Source: the 10-K filed with the SEC on Jun 9, 2014. SEC
- What are UROPLASTY INC's total assets?
- As of Mar 31, 2014, UROPLASTY INC reported total assets of $17.3 million, against $20 million a year earlier (-13.7%). Source: the 10-K filed with the SEC on Jun 9, 2014. SEC
- What are UROPLASTY INC's total liabilities?
- As of Mar 31, 2014, UROPLASTY INC reported total liabilities of $4.1 million, against $3.4 million a year earlier (+21.8%). Source: the 10-K filed with the SEC on Jun 9, 2014. SEC
- What are UROPLASTY INC's cash and cash equivalents?
- As of Mar 31, 2014, UROPLASTY INC reported cash and cash equivalents of $8.7 million, against $3.5 million a year earlier (+145.7%). Source: the 10-K filed with the SEC on Jun 9, 2014. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:890846&period_type=annual&limit=5"Information only, not investment advice.